A Study in Pregnant Women With Chronic Inflammatory Diseases Treated With Cimzia (Certolizumab Pegol)

Summary

The purpose of the study is to assess systemic certolizumab pegol (CZP) exposure, the formation of anti-CZP antibodies and safety of CZP across the course of pregnancy in study participants with chronic inflammatory diseases.

Timeline

Start

2020-06-19

Primary completion

2023-05-23

Completion

2023-05-23

Publications

• Clowse MEB, Dolhain RJEM, Finzel S, Forger F, Glaser C, Pluma A, Shaughnessy L, Sidhu J, Greenin J, Rice K, Utturkar G, Duarte JN, Teil M. Pharmacokinetics of Certolizumab Pegol in Pregnancy: Results from the Open-Label CHERISH Study. Rheumatol Ther. 2026 Jun;13(3):813-828. doi: 10.1007/s40744-026-00853-2. Epub 2026 Apr 21.

Drugs

Indications